What question did this study set out to answer?

Evaluate how classifying vulvodynia patients into subgroups affects treatment outcomes and identifies successful interventions.

(046) Treatment Outcomes Across Vulvodynia Subgroups: A Phenotype-Based Approach

View Full Paper

Ask AI

Bookmark

Authors

This retrospective study evaluates treatment success across vulvodynia subgroups, suggesting targeted therapies improve outcomes.

Evaluate how classifying vulvodynia patients into subgroups affects treatment outcomes and identifies successful interventions.
Conducted a retrospective chart review of diagnosed vulvodynia patients.
Categorized patients into five subgroups based on an established classification algorithm.
Collected demographic data and complete treatment histories from medical records.
Analyzed treatment success using chi-square tests for statistical significance.
Found 227 diagnosed patients, with the most common subtypes being hormonal and pelvic floor dysfunction.
Overall, 86.8% of patients with known outcomes reported clinical improvement.
Estrogen/testosterone therapy showed a success rate of 55.9% overall, with hormonal subtypes responding better compared to non-hormonal subtypes (70.0% vs 35.7%, p < 0.05).
Amitriptyline had the highest specific success rate at 70.0%, although not significantly different from other treatments.
Pelvic floor physical therapy showed limited efficacy.

Gervas et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark